title: Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.
abstract: Nonmedical use of the prescription opioid analgesic oxycodone is a major problem in the United States, particularly among adolescents and young adults. This study characterized self-administration of oxycodone by adolescent and adult mice, and how this affects striatal dopamine levels. Male C57BL/6J mice (4 or 10 weeks old) were allowed to acquire oxycodone self-administration (0.25 mg/kg per infusion) for 9 days, and then tested with varying doses of oxycodone (0, 0.125, 0.25, 0.5, and 0.75 mg/kg per infusion). On completion of the self-administration study, a guide cannula was implanted into the striatum of these mice. Six days later, microdialysis was conducted on the freely moving mouse. After collection of baseline samples, oxycodone was administered i.p. (1.25, 2.5, and 5.0 mg/kg) and samples were collected for 1 h after each dose. Adult mice self-administered significantly more oxycodone across the doses tested. After 1 week, basal striatal dopamine levels were lower in mice of both ages that had self-administered oxycodone than in yoked saline controls. Oxycodone challenge increased striatal dopamine levels in a dose-dependent manner in both age groups. Of interest, the lowest dose of oxycodone led to increased striatal dopamine levels in the mice that had self-administered oxycodone during adolescence but not those that self-administered it as adults. The lower number of infusions of oxycodone self-administered by adolescent mice, and their later increased striatal dopamine in response to the lowest dose of oxycodone (not found in adults), suggest differential sensitivity to the reinforcing and neurobiological effects of oxycodone in the younger mice.
authors.affiliation: The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA. zhangyo@rockefeller.edu
authors.forename: Yong
authors.initials: Y
authors.lastname: Zhang
authors.forename: Roberto
authors.initials: R
authors.lastname: Picetti
authors.forename: Eduardo R
authors.initials: ER
authors.lastname: Butelman
authors.forename: Stefan D
authors.initials: SD
authors.lastname: Schlussman
authors.forename: Ann
authors.initials: A
authors.lastname: Ho
authors.forename: Mary Jeanne
authors.initials: MJ
authors.lastname: Kreek
mesh_terms: D000375:Aging; D000704:Analysis of Variance; D000818:Animals; D016739:Behavior, Addictive; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005108:Extinction, Psychological; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D015233:Models, Statistical; D010098:Oxycodone / Q000008:administration & dosage*; D012646:Self Administration
chemical_list: D010098:Oxycodone; D004298:Dopamine
references.citation: Int J Addict. 1992 Nov;27(11):1313-23
references.pmid: 1446964
references.citation: J Pharmacol Exp Ther. 2005 Aug;314(2):596-602
references.pmid: 15860573
references.citation: Neurotoxicol Teratol. 2007 Jan-Feb;29(1):57-65
references.pmid: 17184971
references.citation: J Pharmacol Exp Ther. 1995 May;273(2):591-8
references.pmid: 7752060
references.citation: Neuroscience. 1998 Mar;83(1):169-76
references.pmid: 9466407
references.citation: Drug Alcohol Depend. 1999 Oct 1;56(3):205-12
references.pmid: 10529022
references.citation: Drugs. 2003;63(1):17-32
references.pmid: 12487620
references.citation: Eur J Pharmacol. 2005 Dec 28;528(1-3):119-23
references.pmid: 16321380
references.citation: Psychopharmacology (Berl). 2004 Sep;175(3):265-73
references.pmid: 15098085
references.citation: Pharmacol Biochem Behav. 2005 Mar;80(3):411-7
references.pmid: 15740783
references.citation: Synapse. 1995 Oct;21(2):140-8
references.pmid: 8584975
references.citation: J Pharmacol Exp Ther. 1995 Feb;272(2):781-5
references.pmid: 7853194
references.citation: Environ Health Perspect. 2003 Apr;111(4):395-401
references.pmid: 12676589
references.citation: Curr Drug Deliv. 2008 Jan;5(1):55-8
references.pmid: 18220551
references.citation: Brain Res. 2001 Dec 27;923(1-2):172-7
references.pmid: 11743985
references.citation: J Pharmacol Exp Ther. 1995 Feb;272(2):652-7
references.pmid: 7853178
references.citation: Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):184-7
references.pmid: 10095091
references.citation: J Neurosci. 2006 Mar 8;26(10):2645-51
references.pmid: 16525043
references.citation: Pharmacol Biochem Behav. 2003 Mar;74(4):917-31
references.pmid: 12667907
references.citation: Neurotoxicol Teratol. 2007 Jul-Aug;29(4):458-65
references.pmid: 17433619
references.citation: Brain Res. 2000 Oct 20;881(1):69-72
references.pmid: 11033095
references.citation: Psychopharmacology (Berl). 2004 Jul;174(3):389-95
references.pmid: 14740150
references.citation: Eur J Pharmacol. 2006 Nov 21;550(1-3):95-106
references.pmid: 17011546
references.citation: Drugs. 1996 May;51(5):713-37
references.pmid: 8861543
references.citation: Eur J Pharmacol. 1992 Oct 20;221(2-3):227-34
references.pmid: 1426002
references.citation: Brain Res. 2002 Jan 11;924(2):141-50
references.pmid: 11750899
references.citation: Pharmacol Biochem Behav. 2001 Dec;70(4):475-89
references.pmid: 11796147
references.citation: Neuropsychopharmacology. 2008 Apr;33(5):1097-112
references.pmid: 17593930
references.citation: Synapse. 2003 Dec 1;50(3):191-9
references.pmid: 14515336
references.citation: Neuropsychopharmacology. 2007 Mar;32(3):625-37
references.pmid: 16794567
references.citation: Physiol Behav. 2000 Feb;68(4):487-93
references.pmid: 10713288
references.citation: Dev Neurosci. 1999;21(1):43-9
references.pmid: 10077701
references.citation: Neuropsychopharmacology. 2005 Apr;30(4):705-12
references.pmid: 15496937
references.citation: Psychopharmacology (Berl). 2003 Sep;169(2):141-9
references.pmid: 12764575
references.citation: Behav Brain Res. 1982 Mar;4(3):279-88
references.pmid: 6277348
references.citation: Brain Res Dev Brain Res. 1995 Nov 21;89(2):167-72
references.pmid: 8612321
references.citation: J Neurochem. 1989 May;52(5):1582-9
references.pmid: 2709014
references.citation: Brain Res. 1991 Dec 6;566(1-2):348-50
references.pmid: 1814554
references.citation: Behav Neural Biol. 1979 Aug;26(4):401-15
references.pmid: 574000
references.citation: Neurosci Lett. 1987 Oct 16;81(1-2):227-31
references.pmid: 3696469
references.citation: Neuropsychopharmacology. 2007 Mar;32(3):700-9
references.pmid: 16794562
references.citation: Physiol Behav. 2002 Sep;77(1):107-14
references.pmid: 12213508
references.citation: Neuropsychopharmacology. 2007 Mar;32(3):607-15
references.pmid: 16823391
references.citation: Neuropsychopharmacology. 2008 Mar;33(4):739-48
references.pmid: 17507913